Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The Australia 3D printing medical devices market was valued at USD 158.33 Million in 2025, driven are the growing demand for patient-specific implants and prosthetics and increasing government and private investments in healthcare innovation and additive manufacturing in the region. The market is anticipated to grow at a CAGR of 15.80% during the forecast period of 2026-2035, with the values likely to reach USD 686.51 Million by 2035. The market is further supported by the increasing adoption of personalized healthcare solutions and integration of 3D printing in surgical planning. Advancements in biocompatible materials and rising collaboration between research institutions and medtech firms are expected to fuel growth during the forecast period.
Australia’s aging population and growing prevalence of chronic diseases have created demand for customized implants and prosthetics that enhance patient comfort and reduce surgical complications. 3D printing allows clinicians to produce anatomically accurate devices tailored to individual patients, improving treatment outcomes, particularly in orthopedics, maxillofacial surgery, and dental applications. In addition, Australian hospitals are integrating 3D printing technologies into pre-surgical planning, enabling surgeons to rehearse complex procedures using 3D-printed anatomical models. These models improve accuracy, reduce operation times, and enhance patient safety, thereby boosting market growth.
The Australia 3D printing medical devices market faces mounting supply chain challenges stemming from the Iran-US-Israel conflict that began on February 28, 2026. Australia, while geographically distant from the conflict zone, is deeply integrated into global shipping networks that have been disrupted by the closure of the Strait of Hormuz and ongoing Houthi attacks on commercial vessels. Medical-grade titanium powders, biocompatible polymers, and specialized resins used in 3D-printed implants and surgical tools predominantly ship from European and North American suppliers through routes now subject to significant delays.
The conflict has driven energy prices sharply higher, with Brent crude exceeding USD 110 per barrel. For Australian manufacturers operating metal 3D printers such as selective laser melting systems, the energy cost of running these machines has risen substantially. The UN has reported that Middle East war shockwaves are rippling through Asia-Pacific fuel and supply chains, and Australia is no exception. Rising diesel and electricity costs are increasing the per-unit cost of 3D-printed medical components.
The cyberattack on Stryker by pro-Iranian hackers in March 2026, which disrupted manufacturing and shipment operations, has also affected Australian hospitals that import orthopedic implants and surgical instruments from the US medical device giant. Some elective surgeries requiring customized 3D-printed implants have been delayed as replacement shipments reroute through longer maritime paths.
On the domestic front, Australian 3D printing firms are positioning themselves to fill supply gaps. The country's strong regulatory framework through the Therapeutic Goods Administration provides a pathway for locally produced devices, and several firms are scaling up production of patient-specific implants to reduce reliance on overseas supply chains.
Government: Australian health authorities are working with the Therapeutic Goods Administration to streamline approvals for domestically 3D-printed medical devices. The government is reviewing critical medical supply vulnerability assessments in light of shipping disruptions. Cybersecurity guidelines for medical device importers are being updated.
Market: Metal powder and polymer resin costs are increasing due to extended shipping routes and energy price inflation. Elective surgery delays are occurring where imported 3D-printed implants face supply interruptions. Domestic 3D printing service providers are gaining market traction as import timelines lengthen.
Procurement: Procurement teams should evaluate Australian-based 3D printing suppliers as alternatives to disrupted import channels. Securing long-term contracts for titanium and polymer feedstocks at current prices can hedge against further increases. Building strategic inventory reserves of high-demand implant sizes is recommended.
Base Year
Historical Period
Forecast Period
An estimated 1.3 million Australian adults or 6.7% of the population are living with heart, stroke, or vascular diseases, including around 600,000 affected by coronary heart disease. This growing burden of cardiovascular conditions is driving increased demand for patient-specific 3D printed implants, surgical guides, and anatomical models.
In July 2024, Aibuild partnered with Hyperion Systems to integrate AI-driven automation in large-format 3D printing across Australia, enhancing precision and efficiency, thereby accelerating growth in the Australian 3D printing medical devices market.
A key trend in market is increased government financial support. For instance, in June 2024, BellaSeno received Queensland funding to establish a fully automated 3D-printed resorbable scaffold manufacturing facility.
Compound Annual Growth Rate
15.8%
Value in USD Million
2026-2035
*this image is indicative*
The market is primarily driven by the growing demand for patient-specific implants, prosthetics, and surgical tools, as well as rising investments from both government and private sectors in healthcare innovation and additive manufacturing capabilities. In Australia, the 3D printing medical devices market has grown steadily due to rising healthcare innovation, supportive regulations, and increasing demand for personalized treatment. In 2025, the market was valued at USD 158.33 Million, reflecting strong adoption and investment. Continued technological advancements and clinical integration are expected to drive further expansion in the coming years.
Rising Osteoarthritis Prevalence to Elevate the Market Growth
The growing incidence of osteoarthritis in Australia is a major growth driver for the 3D printing medical devices market. According to the Australian Institute of Health and Welfare, approximately 2.1 million Australians, or 8.3% of the population, were living with osteoarthritis in 2022, with a higher prevalence among females, with 10%, compared to males, with 6.1%. Osteoarthritis, a degenerative joint disease, often requires personalized treatment solutions such as custom implants and prosthetics. The ability of 3D printing technology to produce patient-specific medical devices with enhanced precision and faster turnaround times is increasingly meeting this demand. Consequently, the rising osteoarthritis patient population is expected to significantly propel market growth for 3D printing medical devices in the coming years.
Some of the key trends in the market include miniaturization, precision, as well as advancements in point-of-care 3D printing.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Component
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Medical Implants to Lead the Segmentation by Application
The medical implants segment is expected to lead the market, driven by breakthroughs in custom-made 3D printed bone scaffolds. For instance, in January 2025, clinicians at the University of Queensland (UQ) successfully used biocompatible, patient-specific 3D printed scaffolds to rebuild a man’s jawbone, eliminating the need for secondary surgeries. This innovation highlights the segment’s potential for personalized and effective treatment solutions. Other key application areas include prosthetics, wearable devices, tissue engineering, dental, and others, each contributing to market growth through technological advancements and increasing adoption. The demonstrated success of UQ’s polycaprolactone (PCL) scaffolds in dental reconstructive surgery also reinforces the expanding role of 3D printing in medical implants and regenerative medicine.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Koninklijke Philips N.V., established in 1891 and headquartered in the Netherlands, is a leading innovator in the 3D printing medical devices market. Through its Phillips Additives, the company offers advanced metal and composite 3D printing solutions, enabling the production of precise, durable medical device components. Philips collaborates with top additive manufacturing brands to enhance device manufacturing efficiency and complexity.
Headquartered in Chicago, Illinois, GE Healthcare is actively involved in the 3D printing medical devices market, focusing on advanced additive manufacturing technologies. In 2022, it partnered with Orchid Orthopedic Solutions to develop electron beam melting (EBM) systems for the accessible production of large joint orthopedic implants, enhancing precision and cost-effectiveness in implant manufacturing.
Stratasys is a leading company in the 3D printing medical devices market. It offers ISO 13485-certified 3D printing services for medical devices and anatomical models. Stratasys supports patient-specific device manufacturing using over 50 industrial-grade materials, enhancing precision and customization in medical applications globally, including Australia.
Founded in 2013 and headquartered in France, PRODWAYS GROUP specializes in 3D printing technologies for the dental industry. Their patented MOVINGLight technology enables efficient production of dental parts such as aligners, dentures, crowns, and bridges. PRODWAYS provides high-performance materials and printers designed to enhance precision and scalability, significantly advancing 3D printing medical devices worldwide.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Nikon SLM Solutions AG, Materialise NV, CELLINK, Anatomics Pty Ltd., and Johnson & Johnson MedTech.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Component |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share